
BACR Annual Meeting 2026
Program Registration Abstract Venue Sponsors
The online abstract book will become available HERE.
Scientific committee: BACR Board
| 9:00 | Registration, poster mounting & coffee |
| 9:30 – 12:15 | MORNING SESSION Chair: TBD |
| 9:30 | Welcome |
| 9:45 |
Invited speaker 1
Mohamed Bentires-Alj, Université de Bâle, Switzerland |
| 10:15 |
Invited speaker 2
François Lucia, Centre Hospitalier Universitaire de Brest, France |
| 10:45 | Coffee break & POSTER SESSION 1 (odd numbers) |
| 11:15 | Young investigators: oral presentations of 4 selected abstracts Selected abstract 1
Jorrit De Waele, University of Antwerp Integrated immune profiling and functional validation support RANKL, TIGIT, and CD47 triple blockade as a cervical cancer-specific immunotherapeutic strategy
Selected abstract 2
Sam Ernst, University of Ghent Three-dimensional patient-derived tumor fragments enable functional ex vivo profiling of treatment response in solid tumors Selected abstract 3
Vincent Wuidar, Université de Liège Shaping ERa activity with pulsed estrogens prevents breast tumor growth and enables safer menopausal hormone therapy Selected abstract 4
Aurélien Potter, Université Catholique de Louvain Ferroptosis as a therapeutic vulnerability in TP53-mutated acute myeloid leukemia |
| 12:15 | BACR: general assembly (members only) |
| 12:30 – 14:00 | LUNCH AND POSTER SESSION 2 (even numbers) |
| 14:00 – 16:45 | AFTERNOON SESSION Chair: TBD |
| 14:00 | Young investigators: oral presentations of 4 selected abstracts
Selected abstract 5
Clémence François, Université Catholique de Louvain Immunospheroid, a 3D framework for the advancement of immunotherapy Selected abstract 6
Ran Gao, Université de Liège Tumor-intrinsic mTORC2 signaling reprograms tissue-resident alveolar macrophages to promote immunosuppression and lung cancer progression Selected abstract 7
Hannah Zaryouh, University of Antwerp Escaping resistance: EGFR and PI3K co-targeting re-establishes therapeutic response in head and neck cancer Selected abstract 8
Mikael Olefs, University of Ghent Disrupting Rab27b-Melanophilin-Dependent Extracellular Vesicle Secretion Impairs DNA Clearance and Promotes Immune Activation in ER-Positive Breast Cancer |
| 15:00 | Coffee break |
| 15:30 |
Invited speaker 3
Nelson Dusetti, Centre de Recherche en Cancérologie Marseille, France
From Predictive Signatures to the Biology of Therapy Resistance in Pancreatic Cancer |
| 16:00 |
Invited speaker 4
Marie-Julie Nokin, Université de Liège, Belgium
Targeting Metabolic Vulnerabilities in Drug Tolerant BRAF Mutated Lung Cancer |
| 16:30 | Awards ceremony for best oral and poster presentations Concluding remarks |
| 17:00 | End of the conference |
